Cargando…

A meta-analysis of renal outcomes in living kidney donors

Given the increased burden of end-stage renal disease (ESRD), renal outcomes of kidney donation by living donors are of particular interest. PubMed, ProQuest, MEDLINE, EMBASE, Chinese national knowledge infrastructure, and Wanfang databases were searched for clinical outcomes of living kidney donors...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Sha-Sha, Huang, Yan-Mei, Wang, Min, Shen, Jian, Lin, Bing-Jie, Sui, Yi, Zhao, Hai-Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998450/
https://www.ncbi.nlm.nih.gov/pubmed/27310964
http://dx.doi.org/10.1097/MD.0000000000003847
_version_ 1782449945320620032
author Li, Sha-Sha
Huang, Yan-Mei
Wang, Min
Shen, Jian
Lin, Bing-Jie
Sui, Yi
Zhao, Hai-Lu
author_facet Li, Sha-Sha
Huang, Yan-Mei
Wang, Min
Shen, Jian
Lin, Bing-Jie
Sui, Yi
Zhao, Hai-Lu
author_sort Li, Sha-Sha
collection PubMed
description Given the increased burden of end-stage renal disease (ESRD), renal outcomes of kidney donation by living donors are of particular interest. PubMed, ProQuest, MEDLINE, EMBASE, Chinese national knowledge infrastructure, and Wanfang databases were searched for clinical outcomes of living kidney donors (LKDs) including renal death, ESRD, proteinuria/albuminuria, and renal function after donation. We included 62 studies from 19 countries involving 114,783 kidney donors and nondonors to evaluate the renal consequences less than 6 months, 6 months to 5 years, 5 to 10 years, and 10 years onward after donation. The pooled data showed that uninephrectomy significantly decreased glomerular filtration rate and creatinine clearance rate in parallel with increased serum creatinine concentration (all P < 0.05). The drastic changes in renal function occurred within 6 months rather than 5 to 10 years after donation. Ten years and onward, rate of proteinuria/albuminuria increased gradually: microalbuminuria from 5.3% to 20.9%, proteinuria from 4.7% to 18.9%, and overt proteinuria from 2.4% to 5.7% (all P < 0.05). Prevalence of ESRD was 1.1%. All-cause mortality was 3.8% and all the renal deaths on average occurred 10 years postnephrectomy. LKDs might have aggravated glomerular filtration and creatinine clearance within 6 months after donation. Five years and onward, albuminuria, proteinuria, ESRD, and death might be the major concerns of LKDs. Long-term studies may clarify the survival time after donation.
format Online
Article
Text
id pubmed-4998450
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49984502016-09-02 A meta-analysis of renal outcomes in living kidney donors Li, Sha-Sha Huang, Yan-Mei Wang, Min Shen, Jian Lin, Bing-Jie Sui, Yi Zhao, Hai-Lu Medicine (Baltimore) 5200 Given the increased burden of end-stage renal disease (ESRD), renal outcomes of kidney donation by living donors are of particular interest. PubMed, ProQuest, MEDLINE, EMBASE, Chinese national knowledge infrastructure, and Wanfang databases were searched for clinical outcomes of living kidney donors (LKDs) including renal death, ESRD, proteinuria/albuminuria, and renal function after donation. We included 62 studies from 19 countries involving 114,783 kidney donors and nondonors to evaluate the renal consequences less than 6 months, 6 months to 5 years, 5 to 10 years, and 10 years onward after donation. The pooled data showed that uninephrectomy significantly decreased glomerular filtration rate and creatinine clearance rate in parallel with increased serum creatinine concentration (all P < 0.05). The drastic changes in renal function occurred within 6 months rather than 5 to 10 years after donation. Ten years and onward, rate of proteinuria/albuminuria increased gradually: microalbuminuria from 5.3% to 20.9%, proteinuria from 4.7% to 18.9%, and overt proteinuria from 2.4% to 5.7% (all P < 0.05). Prevalence of ESRD was 1.1%. All-cause mortality was 3.8% and all the renal deaths on average occurred 10 years postnephrectomy. LKDs might have aggravated glomerular filtration and creatinine clearance within 6 months after donation. Five years and onward, albuminuria, proteinuria, ESRD, and death might be the major concerns of LKDs. Long-term studies may clarify the survival time after donation. Wolters Kluwer Health 2016-06-17 /pmc/articles/PMC4998450/ /pubmed/27310964 http://dx.doi.org/10.1097/MD.0000000000003847 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5200
Li, Sha-Sha
Huang, Yan-Mei
Wang, Min
Shen, Jian
Lin, Bing-Jie
Sui, Yi
Zhao, Hai-Lu
A meta-analysis of renal outcomes in living kidney donors
title A meta-analysis of renal outcomes in living kidney donors
title_full A meta-analysis of renal outcomes in living kidney donors
title_fullStr A meta-analysis of renal outcomes in living kidney donors
title_full_unstemmed A meta-analysis of renal outcomes in living kidney donors
title_short A meta-analysis of renal outcomes in living kidney donors
title_sort meta-analysis of renal outcomes in living kidney donors
topic 5200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998450/
https://www.ncbi.nlm.nih.gov/pubmed/27310964
http://dx.doi.org/10.1097/MD.0000000000003847
work_keys_str_mv AT lishasha ametaanalysisofrenaloutcomesinlivingkidneydonors
AT huangyanmei ametaanalysisofrenaloutcomesinlivingkidneydonors
AT wangmin ametaanalysisofrenaloutcomesinlivingkidneydonors
AT shenjian ametaanalysisofrenaloutcomesinlivingkidneydonors
AT linbingjie ametaanalysisofrenaloutcomesinlivingkidneydonors
AT suiyi ametaanalysisofrenaloutcomesinlivingkidneydonors
AT zhaohailu ametaanalysisofrenaloutcomesinlivingkidneydonors
AT lishasha metaanalysisofrenaloutcomesinlivingkidneydonors
AT huangyanmei metaanalysisofrenaloutcomesinlivingkidneydonors
AT wangmin metaanalysisofrenaloutcomesinlivingkidneydonors
AT shenjian metaanalysisofrenaloutcomesinlivingkidneydonors
AT linbingjie metaanalysisofrenaloutcomesinlivingkidneydonors
AT suiyi metaanalysisofrenaloutcomesinlivingkidneydonors
AT zhaohailu metaanalysisofrenaloutcomesinlivingkidneydonors